Quest Diagnostics Recognized for Excellence in Healthcare Innovation and Social Responsibility
- Quest Diagnostics ranks second in Fortune's 2026 World's Most Admired Companies™ for its commitment to quality and innovation.
- The company provides vital diagnostic insights, serving one in three adult Americans and supporting healthcare management.
- Quest Diagnostics emphasizes social responsibility and continuous improvement in services to enhance patient health outcomes.
Quest Diagnostics: A Leader in Diagnostic Innovation and Social Responsibility
Quest Diagnostics stands out in the healthcare landscape as it earns a spot on Fortune magazine's 2026 World's Most Admired Companies™ list for the twelfth consecutive year. Ranking second in the "Health Care: Pharmacy and Other Services" category, the company's achievement underscores the relentless dedication of its 55,000 employees. CEO Jim Davis emphasizes that this recognition is a testament to the organization’s mission to foster a healthier world, driven by the commitment to quality, innovation, and social responsibility. The evaluation, conducted in partnership with Korn Ferry, includes insights from thousands of executives, directors, and analysts who assessed nearly 700 companies across various industries.
The recognition underscores Quest Diagnostics' critical role in the healthcare ecosystem, where it provides vital diagnostic insights that empower patients, physicians, and healthcare organizations. With access to one of the largest databases of de-identified clinical lab results, Quest enhances the identification and treatment of diseases while promoting preventive healthcare measures. This capability not only helps improve health outcomes but also supports healthcare management at multiple levels, making it an essential player in the industry. By serving approximately one in three adult Americans and half of U.S. physicians and hospitals, Quest Diagnostics remains steadfast in its commitment to transforming lives through actionable insights derived from laboratory testing.
The company's esteemed position in the industry is reinforced by its focus on nine key attributes that reflect its strong reputation, such as product quality and innovation. This recognition from Fortune serves as a reminder of Quest's ongoing commitment to delivering top-tier healthcare solutions. As the healthcare landscape continues to evolve, Quest Diagnostics remains dedicated to its mission, ensuring that it adapts and grows in response to the needs of its patients and the healthcare community.
In addition to its recent accolades, Quest Diagnostics continues to enhance its services and offerings. The company is actively involved in promoting healthy behaviors and improving healthcare management, ensuring that it remains at the forefront of diagnostic innovation. By focusing on research and development, Quest is well-positioned to address the challenges of modern healthcare, ultimately contributing to a healthier society.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

